VGLL4 levels in cancer cells are typically lower compared to normal tissues, and reduced expression of VGLL4 is often associated with poor survival outcomes in numerous cancers, including lung, gastric, breast, colorectal, bladder, pancreatic adenocarcinoma, and esophageal squamous cancer. The gene discussed is VGLL4; the disease is cancer.